Logo image of COVH.PA

COVIVIO HOTELS SACA (COVH.PA) Stock Fundamental Analysis

Europe - EPA:COVH - FR0000060303 - REIT

22.3 EUR
-0.9 (-3.88%)
Last: 11/12/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to COVH. COVH was compared to 38 industry peers in the Diversified REITs industry. COVH has an average financial health and profitability rating. COVH is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

COVH had positive earnings in the past year.
COVH had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: COVH reported negative net income in multiple years.
In the past 5 years COVH always reported a positive cash flow from operatings.
COVH.PA Yearly Net Income VS EBIT VS OCF VS FCFCOVH.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

COVH has a Return On Assets (2.89%) which is comparable to the rest of the industry.
COVH has a Return On Equity of 5.88%. This is in the better half of the industry: COVH outperforms 60.53% of its industry peers.
COVH has a Return On Invested Capital (3.68%) which is in line with its industry peers.
COVH had an Average Return On Invested Capital over the past 3 years of 3.85%. This is in line with the industry average of 3.49%.
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROIC 3.68%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
COVH.PA Yearly ROA, ROE, ROICCOVH.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

The Profit Margin of COVH (78.96%) is better than 86.84% of its industry peers.
COVH's Profit Margin has declined in the last couple of years.
COVH's Operating Margin of 101.55% is amongst the best of the industry. COVH outperforms 100.00% of its industry peers.
COVH's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 101.55%
PM (TTM) 78.96%
GM N/A
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
COVH.PA Yearly Profit, Operating, Gross MarginsCOVH.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

4

2. Health

2.1 Basic Checks

COVH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, COVH has about the same amount of shares outstanding.
Compared to 5 years ago, COVH has more shares outstanding
COVH has a worse debt/assets ratio than last year.
COVH.PA Yearly Shares OutstandingCOVH.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M
COVH.PA Yearly Total Debt VS Total AssetsCOVH.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

COVH has an Altman-Z score of 1.01. This is a bad value and indicates that COVH is not financially healthy and even has some risk of bankruptcy.
COVH has a better Altman-Z score (1.01) than 65.79% of its industry peers.
The Debt to FCF ratio of COVH is 12.72, which is on the high side as it means it would take COVH, 12.72 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 12.72, COVH perfoms like the industry average, outperforming 52.63% of the companies in the same industry.
A Debt/Equity ratio of 0.70 indicates that COVH is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.70, COVH perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Altman-Z 1.01
ROIC/WACC0.69
WACC5.33%
COVH.PA Yearly LT Debt VS Equity VS FCFCOVH.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

COVH has a Current Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH has a Current ratio of 1.16. This is amongst the best in the industry. COVH outperforms 89.47% of its industry peers.
COVH has a Quick Ratio of 1.16. This is a normal value and indicates that COVH is financially healthy and should not expect problems in meeting its short term obligations.
COVH has a better Quick ratio (1.16) than 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.16
COVH.PA Yearly Current Assets VS Current LiabilitesCOVH.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

COVH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 241.67%, which is quite impressive.
COVH shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.16% yearly.
Looking at the last year, COVH shows a decrease in Revenue. The Revenue has decreased by -5.26% in the last year.
COVH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.29% yearly.
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%

3.2 Future

COVH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.90% yearly.
The Revenue is expected to grow by 0.55% on average over the next years.
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COVH.PA Yearly Revenue VS EstimatesCOVH.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M 250M
COVH.PA Yearly EPS VS EstimatesCOVH.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2023 2024 2025 2026 0.5 1 1.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.16 indicates a correct valuation of COVH.
COVH's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.34, COVH is valued a bit cheaper.
COVH is valuated correctly with a Price/Forward Earnings ratio of 12.94.
65.79% of the companies in the same industry are cheaper than COVH, based on the Price/Forward Earnings ratio.
COVH is valuated cheaply when we compare the Price/Forward Earnings ratio to 34.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.16
Fwd PE 12.94
COVH.PA Price Earnings VS Forward Price EarningsCOVH.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COVH indicates a somewhat cheap valuation: COVH is cheaper than 60.53% of the companies listed in the same industry.
COVH's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 15.23
EV/EBITDA 16.61
COVH.PA Per share dataCOVH.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)5.36
PEG (5Y)N/A
EPS Next 2Y0.9%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

COVH has a Yearly Dividend Yield of 6.49%, which is a nice return.
COVH's Dividend Yield is a higher than the industry average which is at 5.98.
Compared to an average S&P500 Dividend Yield of 2.36, COVH pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.49%

5.2 History

The dividend of COVH decreases each year by -3.01%.
Dividend Growth(5Y)-3.01%
Div Incr Years4
Div Non Decr Years4
COVH.PA Yearly Dividends per shareCOVH.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

COVH pays out 19.16% of its income as dividend. This is a sustainable payout ratio.
DP19.16%
EPS Next 2Y0.9%
EPS Next 3YN/A
COVH.PA Yearly Income VS Free CF VS DividendCOVH.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M
COVH.PA Dividend Payout.COVH.PA Dividend Payout, showing the Payout Ratio.COVH.PA Dividend Payout.PayoutRetained Earnings

COVIVIO HOTELS SACA

EPA:COVH (11/12/2025, 7:00:00 PM)

22.3

-0.9 (-3.88%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16
Inst Owners31.31%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap3.52B
Revenue(TTM)260.60M
Net Income(TTM)205.77M
Analysts82.86
Price Target18.67 (-16.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.49%
Yearly Dividend1.3
Dividend Growth(5Y)-3.01%
DP19.16%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 16.16
Fwd PE 12.94
P/S 13.52
P/FCF 15.23
P/OCF 9.64
P/B 1.01
P/tB 1.11
EV/EBITDA 16.61
EPS(TTM)1.38
EY6.19%
EPS(NY)1.72
Fwd EY7.73%
FCF(TTM)1.46
FCFY6.56%
OCF(TTM)2.31
OCFY10.38%
SpS1.65
BVpS22.14
TBVpS20.08
PEG (NY)5.36
PEG (5Y)N/A
Graham Number26.22
Profitability
Industry RankSector Rank
ROA 2.89%
ROE 5.88%
ROCE 4.15%
ROIC 3.68%
ROICexc 4.07%
ROICexgc 4.31%
OM 101.55%
PM (TTM) 78.96%
GM N/A
FCFM 88.74%
ROA(3y)3.26%
ROA(5y)1.11%
ROE(3y)6.53%
ROE(5y)1.93%
ROIC(3y)3.85%
ROIC(5y)2.91%
ROICexc(3y)4.03%
ROICexc(5y)3.03%
ROICexgc(3y)4.17%
ROICexgc(5y)3.12%
ROCE(3y)4.35%
ROCE(5y)3.29%
ROICexgc growth 3Y33.75%
ROICexgc growth 5Y5.13%
ROICexc growth 3Y32.01%
ROICexc growth 5Y4.39%
OM growth 3Y10.91%
OM growth 5Y0%
PM growth 3Y43.44%
PM growth 5Y-10.66%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.7
Debt/FCF 12.72
Debt/EBITDA 6.97
Cap/Depr 152.56%
Cap/Sales 51.52%
Interest Coverage 4.11
Cash Conversion 103.65%
Profit Quality 112.39%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 1.01
F-Score5
WACC5.33%
ROIC/WACC0.69
Cap/Depr(3y)165.18%
Cap/Depr(5y)147.82%
Cap/Sales(3y)30.61%
Cap/Sales(5y)33.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)241.67%
EPS 3Y62.03%
EPS 5Y-12.16%
EPS Q2Q%-15.59%
EPS Next Y3.01%
EPS Next 2Y0.9%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.26%
Revenue growth 3Y14.81%
Revenue growth 5Y2.29%
Sales Q2Q%-12.96%
Revenue Next Year-1.19%
Revenue Next 2Y0.55%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-8.53%
EBIT growth 3Y27.34%
EBIT growth 5Y2.29%
EBIT Next Year-17.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7.29%
FCF growth 3Y35.97%
FCF growth 5Y2.55%
OCF growth 1Y24.43%
OCF growth 3Y30.01%
OCF growth 5Y4.76%

COVIVIO HOTELS SACA / COVH.PA FAQ

What is the fundamental rating for COVH stock?

ChartMill assigns a fundamental rating of 4 / 10 to COVH.PA.


Can you provide the valuation status for COVIVIO HOTELS SACA?

ChartMill assigns a valuation rating of 2 / 10 to COVIVIO HOTELS SACA (COVH.PA). This can be considered as Overvalued.


How profitable is COVIVIO HOTELS SACA (COVH.PA) stock?

COVIVIO HOTELS SACA (COVH.PA) has a profitability rating of 5 / 10.


How financially healthy is COVIVIO HOTELS SACA?

The financial health rating of COVIVIO HOTELS SACA (COVH.PA) is 4 / 10.


Is the dividend of COVIVIO HOTELS SACA sustainable?

The dividend rating of COVIVIO HOTELS SACA (COVH.PA) is 6 / 10 and the dividend payout ratio is 19.16%.